[[3, 7, 547, 35, "Table 2. Functionalized Pyrazole SAR"], [443, 240, 520, 277, "IL-1"], [612, 238, 695, 276, "cLogP"], [34, 262, 160, 288, "Compound"], [270, 262, 302, 288, "R2"], [753, 259, 820, 287, "LLEb"], [421, 277, 541, 307, "IC50 (M)a"], [611, 275, 695, 306, "cLogD"], [633, 335, 676, 364, "2.6"], [80, 352, 116, 380, "14"], [448, 352, 516, 378, "0.086"], [768, 354, 808, 380, "6.2"], [629, 364, 677, 396, "0.9"], [632, 455, 676, 483, "2.4"], [80, 472, 116, 500, "15"], [454, 471, 509, 500, "2.57"], [767, 471, 807, 500, "5.1"], [632, 487, 675, 516, "0.5"], [632, 597, 676, 625, "3.0"], [79, 611, 116, 642, "16"], [454, 614, 507, 642, "0.41"], [767, 613, 810, 642, "5.5"], [632, 629, 675, 658, "0.9"], [402, 756, 562, 785, "0.063  0.042"], [632, 755, 676, 784, "2.0"], [80, 774, 113, 798, "17"], [767, 772, 810, 800, "6.7"], [440, 790, 522, 820, "(n=28)"], [632, 788, 676, 816, "0.4"], [633, 914, 675, 943, "2.1"], [80, 933, 114, 958, "18"], [454, 932, 509, 958, "0.43"], [767, 932, 810, 959, "6.0"], [632, 948, 676, 975, "0.4"], [636, 1075, 676, 1101, "1.8"], [80, 1091, 113, 1117, "19"], [460, 1090, 503, 1119, "6.2"], [768, 1091, 808, 1117, "5.2"], [643, 1108, 664, 1132, "0"], [4, 1204, 848, 1235, "'Inhibition of the NLRP3 inflammasome pathway was assessed by"], [3, 1243, 851, 1272, "quantifying IL-1 release from LPS + nigericin stimulated hPBMCs"], [4, 1278, 851, 1307, "(n = 1 for all compounds except compound 17 which is reported as"], [0, 1311, 853, 1346, "geometric mean  SD). LLE was calculated using the following"], [3, 1348, 495, 1381, "equation: LLE = pICso IL-1 - cLogD."]]